Author

V. K. Viswanathan

Primary ORCID profile (0000-0002-9258-9865 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

V. K. ViswanathaniD1 paper · University of Arizona

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:metagenomics· 2 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

G. Vedantam· 2 shared B. A. P. Roxas· 1 shared B. Trindade· 1 shared D. M. Aronoff· 1 shared D. Maseda· 1 shared E. P. Skaar· 1 shared F. Anwar· 1 shared J. L. Roxas· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

G. Vedantam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Low-Toxin Clostridioides difficile RT027 Strains Exhibit Robust Virulence

F. Anwar, B. A. P. Roxas, K. W. Shehab, N. Ampel, V. K. Viswanathan, G. Vedantam

The paper investigates low-toxin RT027 C. difficile strains and finds they exhibit robust virulence despite being toxin-negative by NAAT, challenging current diagnostic assumptions.

bioRxiv · Mar 18, 2022Microbiology

Nonsteroidal anti-inflammatory drugs alter the microbiota and exacerbate Clostridium difficile colitis while dysregulating the inflammatory response

D. Maseda, J. P. Zackular, B. Trindade, L. Kirk, L. J. Crofford, P. D. Schloss, J. L. Roxas, V. K. Viswanathan, G. Vedantam, L. M. Rogers, M. K. Washington, E. P. Skaar, D. M. Aronoff

This study shows NSAIDs like indomethacin alter gut microbiota and worsen C. difficile colitis by disrupting PG metabolism, epithelial integrity, and immune responses in mice.

bioRxiv · Aug 14, 2018Microbiology